Cargando…

Editorial: Women in head and neck cancer, volume II: 2022

Detalles Bibliográficos
Autores principales:	Economopoulou, Panagiota, Kotsantis, Ioannis, Psyrri, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523560/ https://www.ncbi.nlm.nih.gov/pubmed/37771432 http://dx.doi.org/10.3389/fonc.2023.1278798

Ejemplares similares

Editorial: Women in head and neck cancer 2021
por: Economopoulou, Panagiota, et al.
Publicado: (2022)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

Special Issue about Head and Neck Cancers: HPV Positive Cancers
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Economopoulou, Panagiota, et al.
Publicado: (2021)

Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma
por: Spathas, Nikolaos, et al.
Publicado: (2018)

The Role of B Cells in Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature
por: Tsavaris, Onoufrios, et al.
Publicado: (2018)

Editorial: Women in gastrointestinal cancers, volume II: 2022
por: Hamdy, Nadia M., et al.
Publicado: (2023)

Lymph Node Ratio as a Prognostic Factor in Neck Dissection in Oral Cancer Patients: A Systematic Review and Meta-Analysis
por: Gartagani, Zoi, et al.
Publicado: (2022)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Editorial: Women in molecular and cellular oncology, volume II: 2022
por: Dhar, Shilpa S.
Publicado: (2023)

The DNA damage response network in the treatment of head and neck squamous cell carcinoma
por: Psyrri, A., et al.
Publicado: (2021)

Androgen-Receptor Positive Lacrimal Sac Adenocarcinoma Demonstrating Long-Lasting Response to LHRH Analog Plus Abiraterone Treatment
por: Vagia, Elena, et al.
Publicado: (2015)

Medical management of gastric cancer: a 2017 update
por: Charalampakis, Nikolaos, et al.
Publicado: (2017)

Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Economopoulou, Panagiota, et al.
Publicado: (2021)

Editorial: Women in skin cancer vol II: 2022
por: Ugurel, Selma, et al.
Publicado: (2023)

Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV(+) “low-risk” locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Editorial: Women in surgical oncology vol II: 2022
por: Castagneto-Gissey, Lidia
Publicado: (2023)

Editorial: Women in pediatric oncology Vol II: 2022
por: Kim, Yong-mi, et al.
Publicado: (2023)

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
por: Moutafi, Myrto, et al.
Publicado: (2023)

Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

Editorial: Head and neck cancer in the elderly
por: Szturz, Petr, et al.
Publicado: (2023)

Editorial: Insights in head and neck cancer: 2021
por: Lybaert, Willem, et al.
Publicado: (2023)

Editorial: Women in cancer metabolism: 2021/2022
por: Kaambre, Tuuli
Publicado: (2022)

Systematic Review of Recurrent Osteosarcoma Systemic Therapy
por: Gazouli, Ioanna, et al.
Publicado: (2021)

Tyrosine kinase inhibitors in sarcoma treatment
por: Kyriazoglou, Anastasios, et al.
Publicado: (2022)

Clinical Significance of PD-L1 Status in Circulating Tumor Cells for Cancer Management during Immunotherapy
por: Strati, Areti, et al.
Publicado: (2023)

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)

Editorial: Next generation staging in head and neck cancers
por: Iyer, N. Gopalakrishna, et al.
Publicado: (2022)

HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Editorial: Biomarkers in genitourinary cancers: Volume II
por: Yuasa, Takeshi
Publicado: (2022)

Editorial: Challenges and their implications for the clinical practice of head and neck cancer
por: Wirth, Markus, et al.
Publicado: (2023)

Editorial: Prognosis prediction and risk stratification in head and neck cancer
por: Li, Tengxiang, et al.
Publicado: (2022)

Editorial: Head & Neck Cancer and Esophageal Cancer: From Biosignatures to Therapeutics
por: Kok, Victor C., et al.
Publicado: (2021)

Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma
por: Gavrielatou, Niki, et al.
Publicado: (2023)

Evaluation of PET/MRI for Tumor Volume Delineation for Head and Neck Cancer
por: Wang, Kyle, et al.
Publicado: (2017)

Head and Neck Cancer
por: Psyrri, Amanda, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_079bl2qdeqom19gls5qn35aba1